Detalhe da pesquisa
1.
Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies).
Ann Hematol
; 99(4): 765-772, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062741
2.
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival.
Clin Epigenetics
; 13(1): 9, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446256
3.
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
Leukemia
; 20(1): 87-94, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16281071
4.
Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients.
Leuk Res
; 29(10): 1109-16, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16095690
5.
Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH).
Bone Marrow Transplant
; 36(9): 781-5, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16151427
6.
Azacitidine frontline therapy for unfit acute myeloid leukemia patients: clinical use and outcome prediction.
Leuk Res
; 39(3): 296-306, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601157
7.
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry.
Leukemia
; 29(9): 1875-81, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943181
8.
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
Blood Cancer J
; 5: e352, 2015 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26430723
9.
Blood transfusion has no effect on colorectal cancer survival. A population-based study.
Eur J Cancer
; 30A(6): 759-64, 1994.
Artigo
em Inglês
| MEDLINE | ID: mdl-7917533
10.
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.
Bone Marrow Transplant
; 31(5): 387-92, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12634730
11.
Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients.
Bone Marrow Transplant
; 34(5): 433-8, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15273704
12.
Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Bone Marrow Transplant
; 22(12): 1129-35, 1998 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-9894714
13.
Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation.
Bone Marrow Transplant
; 28(4): 341-7, 2001 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-11571505
14.
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBT.
Bone Marrow Transplant
; 24(7): 723-8, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10516674
15.
Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation.
Bone Marrow Transplant
; 28(4): 349-54, 2001 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-11571506
16.
A simplified method for cryopreservation of hematopoietic stem cells with -80 degrees C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant.
Leuk Lymphoma
; 17(1-2): 181-4, 1995 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-7773157
17.
Pre-B Acute Lymphoblastic Leukemia During a Complete Remission in T-Acute Lymphoblastic Leukemia.
Leuk Lymphoma
; 3(5-6): 443-5, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-27467438
18.
MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia.
Leukemia
; 28(4): 804-12, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24072101
19.
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML.
Leukemia
; 27(11): 2157-64, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23584566
20.
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma.
Leukemia
; 31(6): 1446-1449, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28210002